Lexaria Bioscience
Quarterly Financials
| Values in thousands | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 |
|---|---|---|---|---|
Revenue | $183 | $84 | $84 | $145 |
Gross Profit | 181 | 84 | 84 | 129 |
EBITDA | -2,690 | -2,203 | -1,727 | -636 |
EBIT | -2,195 | -1,742 | -652 | |
Net Income | -2,703 | -2,184 | -1,781 | -649 |
Net Change In Cash | 183 | 84 | 84 | 145 |
Free Cash Flow | -2,726 | -1,961 | -1,288 | -676 |
Cash | 8,078 | 6,499 | 8,459 | 4,705 |
Basic Shares | 16,668 | 14,565 | 13,855 | 10,765 |
Annual Financials
| Values in thousands | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|
Revenue | $464 | $226 | $255 | $722 |
Gross Profit | 459 | 194 | 183 | 547 |
EBITDA | -5,676 | -6,388 | -6,516 | -5,575 |
EBIT | -5,753 | -6,534 | -6,663 | -5,722 |
Net Income | -5,795 | -6,664 | -7,269 | -2,504 |
Net Change In Cash | 464 | 226 | 255 | 722 |
Free Cash Flow | -4,959 | -6,050 | -5,010 | -4,069 |
Cash | 6,499 | 1,352 | 5,813 | 10,917 |
Basic Shares | 12,383 | 6,614 | 5,885 | 4,391 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-11-30 | -$0.16 |
2024-08-31 | -$0.15 |
2024-05-31 | -$0.13 |
2024-02-29 | -$0.06 |
